上海荣泰健康科技股份有限公司关于提前赎回“荣泰转债”的公告

Core Viewpoint - Shanghai Rongtai Health Technology Co., Ltd. has triggered the conditional redemption clause for its convertible bonds due to the stock price exceeding 130% of the conversion price for fifteen trading days, leading to a decision for early redemption of the bonds [2][11][12]. Group 1: Convertible Bond Issuance and Redemption - The company issued 6 million convertible bonds on October 30, 2020, with a total amount of 600 million yuan and a maturity of 6 years [3]. - The initial conversion price was set at 33.32 yuan per share, which has been adjusted multiple times due to profit distribution, with the latest adjustment bringing it to 23.07 yuan per share [5][6][7][8]. - The company’s stock price has been above 29.99 yuan per share for fifteen trading days, triggering the conditional redemption clause as per the bond's offering document [2][11]. Group 2: Redemption Process - The board of directors approved the early redemption of the convertible bonds on August 18, 2025, and will redeem all unconverted bonds at face value plus accrued interest [12][13]. - The management team has been authorized to handle all matters related to the redemption process, including determining the redemption date and procedures [13].